Text Size
9 studies found for:    17021318 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion
Condition: Neovascular Age-related Macular Degeneration
Intervention: Procedure: Intravitreal expansile gas and ranibizumab injection
2 Completed
Has Results 		Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: ranibizumab
3 Completed Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab
Condition: Exudative Age-related Macular Degeneration
Intervention: Drug: intravitreal injection of ranibizumab
4 Withdrawn Ranibizumab for Neovascularization in Sickle Cell Retinopathy
Conditions: Sickle Cell Anemia;   Retinopathy
Intervention: Drug: Ranibizumab
5 Completed Study for Recalcitrant Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: aflibercept 2.0 mg
6 Terminated Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: Ranibizumab (Lucentis)
7 Recruiting Treat and Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Condition: Macular Degeneration
Intervention: Drug: 0.5mg ranibizumab
8 Completed A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)
9 Unknown † Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
Conditions: Macular Degeneration;   Visual Acuity
Intervention: Drug: Ranibizumab
To Top

† Indicates status has not been verified in more than two years